Retinal detachment after bevacizumab

Ophthalmology. 2011 Nov;118(11):2304.e3-7. doi: 10.1016/j.ophtha.2011.05.015.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / adverse effects*
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Bevacizumab
  • Diabetic Retinopathy / drug therapy
  • Diabetic Retinopathy / surgery
  • Disease Progression
  • Female
  • Humans
  • Intravitreal Injections
  • Male
  • Middle Aged
  • Retinal Detachment / etiology*
  • Retinal Neovascularization / drug therapy
  • Retinal Neovascularization / surgery
  • Risk Factors
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Vitrectomy
  • Young Adult

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab